Determination of urinary myo-inositol concentration by an improved enzymatic cycling method using myo-inositol dehydrogenase from Flavobacterium sp

Clin Chim Acta. 2003 Feb;328(1-2):163-71. doi: 10.1016/s0009-8981(02)00426-6.


Background: To determine myo-inositol more accurately, we improved the enzymatic cycling method.

Methods: We screened myo-inositol dehydrogenase (MIDH; EC. from Flavobacterium sp., which was highly specific to myo-inositol. We measured urinary myo-inositol/creatinine ratio 2 h after 75-g oral glucose tolerance test (2 h MI) of 71 volunteers, and investigated the relationship between diabetes and urinary myo-inositol concentration.

Results: The calibration curve was linear (r = 1.00) up to 2000 micromol/l, and the detection limit was 10 micromol/l. Within-run and between-run CVs were 0.5-1.1% and 0.4-1.3%, respectively. The 2 h MI of impaired fasting glycemia (IFG; 65.1 +/- 46.6 mg/g Cr, P < 0.005), impaired glucose tolerance (IGT; 85.0 +/- 73.7 mg/g Cr, P < 0.001) and diabetes (163.4 +/- 73.7 mg/g Cr, P < 0.0001) increased significantly compared with that of normal glucose tolerance (NGT; 24.0 +/- 14.4 mg/g Cr). From receiver operating characteristic analyses on 2 h MI, with 50 mg/g Cr as a tentative cutoff value to detect diabetes, the sensitivity and specificity were 100% and 77%, respectively. With 40 mg/g Cr as a tentative cutoff value to detect NGT, the sensitivity and specificity were 74% and 85%, respectively.

Conclusions: The myo-inositol measurement method demonstrated high specificity and yielded accurate results. The results of clinical trials suggested that 2 h MI could not only determine diabetes but also distinguish IFG and IGT from NGT.

MeSH terms

  • Adult
  • Female
  • Flavobacterium / enzymology*
  • Humans
  • Inositol / urine*
  • Male
  • Middle Aged
  • Phosphoric Monoester Hydrolases / metabolism*
  • Sensitivity and Specificity


  • Inositol
  • Phosphoric Monoester Hydrolases
  • inositol-1,4-bisphosphate 1-phosphatase